Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats- Top 15 Style Creators Changing the Business
- Key Caper d: A Survey of \Procedure and Tomfoolery Released\ Tabletop game
- The Response Uncovered: Disentangling the Secrets of the Universe
- Sudan war ‘being fought on women’s bodies’: Survivors detail sexual assault
- How to Build a Yard That Helps Monarchs During Spring Migration
- When darkness shines: How dark stars could illuminate the early universe
- Wedding Guest Outraged That Bride and Groom, Who Are in Their 60s and Have Both Been Married Before, Registered for Gifts
- The 10 Most Progressive Logical Disclosures
